Abstract:New drug development is an extremely time-consuming and high-risk process. [1]It has been widely valued by the biomedical industry to fully explore the new uses of existing drugs and reorientate them. [2]How to find drug disease with potential therapeutic relationship from a large number of unproven relationship pairs is the research focus of drug reorientation. With the help of machine learning model, we can improve the enrichment degree of potential drug disease relationship pairs, and reduce the false positive rate of prediction. In the past few years, a series of graph based convolutional network models have been developed to calculate the information latent feature representation of nodes and links. Researchers at home and abroad have done a lot of research on network embedding technology based on biomedical data, and have achieved a series of important research results. Among them, the research methods used can be divided into two categories: one is the traditional machine learning algorithm based on artificial feature extraction, the other is the method based on deep learning. For example, kipf and welling [3]proposed a new graph convolution network (GCN) with parts of existing models, DeepDR [4] and DTINet [5] based on node characteristics and their connections, which can be used for node classification. Aiming at the problem of imbalance of drug information data samples, the invention provides a drug relocation method based on deep learning multi-source heterogeneous network. In order to avoid the limitations of traditional feature extraction methods, such as highly dependent on the experience and knowledge of medical staff, strong subjectivity, consuming a lot of time and energy to complete, and extracting high-quality features with distinguishing features often exists In this paper, with the help of graph convolution encoder model and variational auto encoder neural network, we can automatically learn the characteristics of multi-source and heterogeneous drug low-dimensional network, and complete the drug relocation of drug disease association prediction.

Research and Implementation of Drug Relocation Algorithm Based on Deep Learning

deepDR: a network-based deep learning approach to in silico drug repositioning

Implementation of Deep Learning in Drug Design

Drug Repositioning Method Based on Deep Neural Network

A deep learning method for drug-target affinity prediction based on sequence interaction information mining

Drug-target affinity prediction method based on consistent expression of heterogeneous data

A Fused Deep Learning Approach to Transform Novel Drug Repositioning

Deep learning in target prediction and drug repositioning: Recent advances and challenges

Drug repositioning with adaptive graph convolutional networks

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

A Drug Repositioning Algorithm Based on a Deep Autoencoder and Adaptive Fusion

Drug repositioning for Alzheimer's disease with transfer learning

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

A geometric deep learning framework for drug repositioning over heterogeneous information networks

Drug-Target Binding Affinity Prediction by Combination Graph Neural Network and BiLSTM

A deep learning-based method for drug-target interaction prediction based on long short-term memory neural network

Network-Based Approaches for Drug Repositioning.

Machine Learning and Deep Learning Strategies in Drug Repositioning

A Drug Information Embedding Method Based on Graph Convolution Neural Network.

Recent Progress of Deep Learning in Drug Discovery

Attention Transfer in Heterogeneous Networks Fusion for Drug Repositioning